GlassScriptPhysician profile
Kenneth Khaw
NPI 1336119601
$19,646.94
in general payments reported to CMS, 2019-2025
37 companies · $5,322 in 2025
The $5,322 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $2,569 · 2021: $1,503 · 2022: $1,847 · 2023: $4,501 · 2024: $3,301 · 2025: $5,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,448 · Travel and Lodging: $5,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,448.03 |
| Travel and Lodging | $5,676.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,741.67 | 2021-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan, Linq II |
| Boston Scientific Corporation | $2,675.35 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Medtronic Vascular, INC. | $2,092.48 | 2019-2020 | |
| Penumbra, INC. | $1,653.76 | 2023-2024 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $1,594.08 | 2020-2025 | Farxiga, Wainua, Brilinta |
| Abiomed | $902.28 | 2020-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $863.12 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $741.28 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $661.73 | 2019-2024 | Xarelto |
| Stryker Corporation | $643.44 | 2025 | Clottriever Bold Catheter, Flowtriever |
| Pfizer INC. | $502.67 | 2021-2025 | |
| Shockwave Medical, INC | $450.07 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $419.14 | 2020-2025 | (5044) Mcot, (5050) Extended Holter, Extended Holter |
| Merck Sharp & Dohme LLC | $367.30 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $358.17 | 2020-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $292.25 | 2022-2025 | Coroflow, Mitraclip, Xience Sierra |
| Inari Medical, INC. | $285.10 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.89 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $175.76 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $150.16 | 2023 | Optimizer |
| Sunovion Pharmaceuticals INC. | $116.82 | 2019 | |
| Chiesi USA, INC. | $115.93 | 2021 | |
| Edwards Lifesciences Corporation | $107.71 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cardiovascular Systems INC. | $83.90 | 2019-2022 | |
| Cardinal Health 200 LLC | $55.06 | 2019 | |
| Esperion Therapeutics, INC. | $53.87 | 2020-2023 | Nexletol |
| Terumo Medical Corporation | $43.00 | 2019-2023 | Azur Cx Detachable, Progreat |
| Scpharmaceuticals INC. | $36.74 | 2024 | |
| Asahi Intecc USA, INC. | $36.45 | 2025 | Asahi Coronary Wires |
| Kestra Medical Technology Services, INC. | $36.15 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.74 | 2022-2024 | |
| Angiodynamics, INC. | $33.91 | 2023-2024 | Alphavac |
| W. L. Gore & Associates, INC. | $33.65 | 2020-2023 | Gore Cardioform Septal Occluder |
| Novo Nordisk INC | $29.35 | 2021 | |
| Cardiva Medical, INC. | $20.50 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Alnylam Pharmaceuticals INC. | $17.38 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $14.08 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Khaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.